Christiana DellaRusso, PhD is a partner at Providence Ventures, the strategic venture capital arm of Providence St. Joseph Health. At Providence Ventures, DellaRusso focuses on Chronic Disease, Genomics & Precision Medicine, and Behavioral Health & Wellness. She serves on the Board of Directors of precision medicine company N-of-One, and is a Board Observer of digital health company Omada Health.
Prior to joining Providence, DellaRusso was Vice President, Commercialization at Life Science Washington (formerly the WBBA), and Managing Director of WINGS, the Washington Medical Technology Angel Investor Network.
DellaRusso holds a PhD in Physiology from the University of Michigan and completed postdoctoral work at the University of Washington, Harvard Medical School & Children's Hospital Boston.